Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 108,618 $ 118,575
Short-term restricted cash 0 1,003
Accounts receivable, net 105,818 85,464
Inventory 86,031 90,343
Prepaid expenses and other current assets 29,682 28,057
Total current assets 330,149 323,442
Long-term restricted cash 1,635 25
Property and equipment, net 51,125 59,300
Leased right-of-use assets 16,528 18,184
Intangible assets, net 54,359 55,008
Goodwill 318,588 318,588
Deferred tax assets 75,037 68,662
Other long-term assets 16,316 21,430
Total assets 863,737 864,639
Current liabilities:    
Accounts payable 26,860 31,378
Accrued price protection liability 39,520 43,401
Accrued expenses and other current liabilities 120,010 87,408
Accrued compensation 27,102 20,097
Total current liabilities 213,492 182,284
Long-term lease liabilities 14,397 16,952
Long-term debt 123,305 122,996
Other long-term liabilities 24,212 26,124
Total liabilities 375,406 348,356
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 86,908 shares issued and outstanding at June 30, 2025 and 84,613 shares issued and outstanding December 31, 2024 9 8
Additional paid-in capital 928,012 886,823
Accumulated other comprehensive income (loss) 334 (6,823)
Accumulated deficit (440,024) (363,725)
Total stockholders’ equity 488,331 516,283
Total liabilities and stockholders’ equity $ 863,737 $ 864,639